Intrinsic Value
Zynerba Pharmaceuticals, Inc. (ZYNE)
$1.3
+0.03 (+2.36%)
Enterprise Value | - |
---|---|
Net Debt | -50.31 |
Equity Value | - |
Shares Outstanding | 42.66 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt